ÂÜÀòÂÒÂ×

Albert Cha, M.D., Ph.D has served as Chairman of the Board since May 2021 and has served as a member of the Board since November 2014. Dr. Cha previously was a managing partner at Vivo Capital, a healthcare investment firm. He currently serves as a member of the board of directors of Kalvista Pharmaceuticals, Inc. (NASDAQ: KALV). Dr. Cha holds a B.S. and an M.S. from Stanford University and an M.D. and a Ph.D. from the University of California at Los Angeles.